Marketing-authorisation holder
Annora Pharma Private Limited
12 medicines in 1 country, as authorisation holder and manufacturer.
Medicines
Every medicine in the registers under its name, current ones first.
12 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ELTROMBOPAG OLAMINE12.5mg acid/packet | 25mg acid/packet · For suspension | Eltrombopag | United States | Marketed | 2024 |
| EPLERENONE25mg | 50mg · Tablet | Eplerenone | United States | Marketed | 2008 |
| FLUVOXAMINE MALEATE100mg | 150mg · Capsule, extended release | Fluvoxamine | United States | Marketed | 2013 |
| ITRACONAZOLE10mg/ml · Solution | Itraconazole | United States | Marketed | 2015 |
| L-GLUTAMINE5gm/packet · For solution | L-glutamine | United States | Marketed | 2024 |
| METFORMIN HYDROCHLORIDE500mg/5ml · Solution | Metformin | United States | Marketed | 2020 |
| NITAZOXANIDE500mg · Tablet | Nitazoxanida | United States | Marketed | 2020 |
| PANTOPRAZOLE SODIUM40mg base · For suspension, delayed release | Pantoprazole | United States | Marketed | 2020 |
| SAPROPTERIN DIHYDROCHLORIDE100mg · Tablet | Sapropterin | United States | Marketed | 2019 |
| EMPAGLIFLOZIN; LINAGLIPTIN10mg; 5mg | 10mg/5mg | 25mg; 5mg | 25mg/5mg · Tablet | Empagliflozin, Linagliptin | United States | tentative | 2020 |
| GABAPENTIN ENACARBIL600mg · Tablet, extended release | Gabapentin enacarbil | United States | tentative | 2026 |
| TOFACITINIB10mg | 5mg · Tablet | Tofacitinib | United States | tentative | 2024 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 12 | 9 | 3 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- annora
- annora pharma
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 12
- Countries
- 1
- Roles
- Authorisation holder and manufacturer